Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amaury Farce

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|May 23, 2006
A computational view of COX-2 inhibitionPhilippe Chavatte, Amaury Farce
European Journal of Medicinal Chemistry|October 1, 2010
Novel structural insights for drug design of selective 5-HT(2C) inverse agonists from a ligand-biased receptor modelNicolas Renault, Arnaud Gohier, Philippe Chavatte, et al.
Plos Computational Biology|November 7, 2014
Relationships between Th1 or Th2 iNKT cell activity and structures of CD1d-antigen complexes: meta-analysis of CD1d-glycolipids dynamics simulationsXavier Laurent, Nicolas Renault, Amaury Farce, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 22, 2006
Homology modelling of the serotoninergic 5-HT2c receptorAmaury Farce, Sebastien Dilly, Said Yous, et al.
Journal of Biomolecular Structure & Dynamics|August 25, 2006
Differences in binding sites of two melatonin receptors help to explain their selectivity to some melatonin analogs: a molecular modeling studyAnton O Chugunov, Amaury Farce, Philippe Chavatte, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human FarnesyltransferaseAndreea Zubaș, Alina Ghinet, Amaury Farce, et al.
Molecular Informatics|July 24, 2024
Distinct binding hotspots for natural and synthetic agonists of FFA4 from in silico approachesGuillaume Patient, Corentin Bedart, Naim A Khan, et al.
Bioorganic Chemistry|September 6, 2020
Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activityIuliana-Monica Moise, Elena Bîcu, Amaury Farce, et al.
Organic & Biomolecular Chemistry|September 15, 2017
On the discovery of new potent human farnesyltransferase inhibitors: emerging pyroglutamic derivativesGermain Homerin, Emmanuelle Lipka, Benoît Rigo, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2020
Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitorsGermain Homerin, Adrian Sorin Nica, Amaury Farce, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Anti-Cancer Agents in Medicinal Chemistry|May 23, 2006
A computational view of COX-2 inhibitionPhilippe Chavatte, Amaury Farce
European Journal of Medicinal Chemistry|October 1, 2010
Novel structural insights for drug design of selective 5-HT(2C) inverse agonists from a ligand-biased receptor modelNicolas Renault, Arnaud Gohier, Philippe Chavatte, et al.
Plos Computational Biology|November 7, 2014
Relationships between Th1 or Th2 iNKT cell activity and structures of CD1d-antigen complexes: meta-analysis of CD1d-glycolipids dynamics simulationsXavier Laurent, Nicolas Renault, Amaury Farce, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 22, 2006
Homology modelling of the serotoninergic 5-HT2c receptorAmaury Farce, Sebastien Dilly, Said Yous, et al.
Journal of Biomolecular Structure & Dynamics|August 25, 2006
Differences in binding sites of two melatonin receptors help to explain their selectivity to some melatonin analogs: a molecular modeling studyAnton O Chugunov, Amaury Farce, Philippe Chavatte, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human FarnesyltransferaseAndreea Zubaș, Alina Ghinet, Amaury Farce, et al.
Molecular Informatics|July 24, 2024
Distinct binding hotspots for natural and synthetic agonists of FFA4 from in silico approachesGuillaume Patient, Corentin Bedart, Naim A Khan, et al.
Bioorganic Chemistry|September 6, 2020
Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activityIuliana-Monica Moise, Elena Bîcu, Amaury Farce, et al.
Organic & Biomolecular Chemistry|September 15, 2017
On the discovery of new potent human farnesyltransferase inhibitors: emerging pyroglutamic derivativesGermain Homerin, Emmanuelle Lipka, Benoît Rigo, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2020
Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitorsGermain Homerin, Adrian Sorin Nica, Amaury Farce, et al.
Pageof 8